Candel Therapeutics
Candel Therapeutics is a Nasdaq-listed clinical-stage biopharmaceutical company developing multimodal biological immunotherapies, including its lead candidate CAN-2409, to treat cancer.
Company Facts
- Headquarters: Needham, United States
- Type: public
- Website: https://www.candeltx.com
- Industries: Biopharmaceuticals, Immunotherapy, Oncology